Protocol NRG-BR009, A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score less than or equal to 25 (OFSET)
Details
Age
Adult
Locations
Cherry Creek Medical Center
Highlands Ranch Hospital
Lone Tree Medical Center
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital
Principal Investigator
Virginia Borges
Study ID
Protocol Number: 23-2461
More information available at ClinicalTrials.gov: NCT05879926
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers